Sources | Names Used |
---|---|
GDSC1000 | KIN001-102 |
PharmacoGx | KIN001-102 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PDIA6 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
mRNA | PLOD2 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | SLA2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | PHF20L1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | PRR16 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | SLC15A4 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | IFT122 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | ATP5I | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | ADCK5 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | RRAS | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |